Димекс

Основна информация

  • Търговско наименование:
  • Димекс 9,96mg/5ml + 99,6mg/5ml сироп - 125 ml
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици

Документи

Локализация

  • Предлага се в:
  • Димекс 9,96mg/5ml + 99,6mg/5ml сироп - 125 ml
    България
  • Език:
  • български

Терапевтична информация

  • Каталог на резюме:
  • Dimex, 9,96mg/5ml + 99,6mg/5ml syrup - 125 ml

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Номер на разрешението:
  • 20010021
  • Дата Оторизация:
  • 21-05-2012
  • Последна актуализация:
  • 01-06-2018

Няма предупреждения за безопасност за този продукт.

21-9-2018

Scientific guideline:  Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health, draft: consultation open

Scientific guideline: Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health, draft: consultation open

The objective of this document is to review available information on the use of aminopenicillins and their beta-lactamase inhibitor combinations in veterinary medicines in the EU, their effect on the emergence of antimicrobial resistance (AMR) and the potential impact of resistance on human and animal health. The document provides information for the risk profiling, as recommended by the Antimicrobial Advice ad hoc Expert Group (AMEG) of the EMA.

Europe - EMA - European Medicines Agency

21-5-2018

Prescription medicines: new or extended uses, or new combinations of registered medicines

Prescription medicines: new or extended uses, or new combinations of registered medicines

3 medicine registrations added

Therapeutic Goods Administration - Australia